Amélie Bonnefond
Affiliations: | Lille 2 |
Area:
Diabetes, Obesity, Monogenic forms, NGSGoogle:
"Amélie Bonnefond"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burrows K, Heiskala A, Bradfield JP, et al. (2024) A framework for conducting time-varying genome-wide association studies: An application to body mass index across childhood in six multiethnic cohorts. Medrxiv : the Preprint Server For Health Sciences |
| Suzuki K, Hatzikotoulas K, Southam L, et al. (2024) Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature |
| Folon L, Baron M, Scherrer V, et al. (2024) Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes. Diabetes Care |
| Dance A, Fernandes J, Toussaint B, et al. (2023) Exploring the role of purinergic receptor P2RY1 in type 2 diabetes risk and pathophysiology: Insights from human functional genomics. Molecular Metabolism. 101867 |
| Kouidrat Y, Collen LL, Vaxillaire M, et al. (2023) Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: lessons for precision medicine. Diabetes & Metabolism. 101507 |
| Johanns M, Haas JT, Raverdy V, et al. (2023) Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD. Jhep Reports : Innovation in Hepatology. 6: 100948 |
| Meulebrouck S, Scherrer V, Boutry R, et al. (2023) Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia |
| de Las Fuentes L, Schwander KL, Brown MR, et al. (2023) Gene-educational attainment interactions in a multi-population genome-wide meta-analysis identify novel lipid loci. Frontiers in Genetics. 14: 1235337 |
| Fumeron F, Velho G, Alzaid F, et al. (2023) Genetic variants of interferon-response factor 5 are associated with the incidence of chronic kidney disease: the D.E.S.I.R. study. Genes and Immunity. 24: 303-308 |
| Gao W, Liu L, Huh E, et al. (2023) Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity. Nature Metabolism |